UnitedHealth Group (NYSE:UNH) Stock Price Expected to Rise, Jefferies Financial Group Analyst Says

UnitedHealth Group (NYSE:UNHGet Free Report) had its price objective boosted by equities research analysts at Jefferies Financial Group from $317.00 to $409.00 in a research note issued to investors on Friday,Benzinga reports. The firm presently has a “buy” rating on the healthcare conglomerate’s stock. Jefferies Financial Group’s price objective suggests a potential upside of 14.72% from the stock’s previous close.

Other equities research analysts have also recently issued research reports about the company. Bank of America boosted their price objective on UnitedHealth Group from $350.00 to $390.00 and gave the company a “neutral” rating in a research note on Wednesday, October 8th. Weiss Ratings reiterated a “sell (d+)” rating on shares of UnitedHealth Group in a research note on Wednesday, October 8th. Zacks Research upgraded UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research note on Monday, October 6th. Sanford C. Bernstein upped their price target on UnitedHealth Group from $379.00 to $433.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 8th. Finally, Morgan Stanley upped their price target on UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a research note on Friday, September 12th. Eighteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have given a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $385.13.

View Our Latest Analysis on UNH

UnitedHealth Group Stock Performance

Shares of UNH opened at $356.53 on Friday. The stock has a 50 day moving average price of $329.38 and a 200 day moving average price of $343.62. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The company has a market capitalization of $322.90 billion, a price-to-earnings ratio of 15.45, a price-to-earnings-growth ratio of 2.31 and a beta of 0.47. UnitedHealth Group has a 52-week low of $234.60 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same period last year, the company earned $6.80 earnings per share. The business’s revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts predict that UnitedHealth Group will post 29.54 EPS for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the business. LFA Lugano Financial Advisors SA purchased a new position in UnitedHealth Group in the second quarter worth $25,000. Bayforest Capital Ltd grew its holdings in UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 48 shares during the last quarter. Sagard Holdings Management Inc. acquired a new stake in UnitedHealth Group in the second quarter valued at $29,000. Islay Capital Management LLC acquired a new stake in UnitedHealth Group in the second quarter valued at $31,000. Finally, Clal Insurance Enterprises Holdings Ltd grew its holdings in UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after purchasing an additional 50 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Company Profile

(Get Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.